Michiko Yamamoto
- Nephrology top 2%
- Parathyroid Disorders and Treatments 10
- Oncology top 2%
- Bone health and treatments 16
- Colorectal Cancer Treatments and Studies 7
- Molecular Biology top 10%
- Bone Metabolism and Diseases 13
-
- Thyroid Disorders and Treatments 10
-
- Lung Cancer Treatments and Mutations 9
-
- Pharmacy and Medical Practices 8
-
- Pharmacovigilance and Adverse Drug Reactions 7
- Co-authors
- Takuhiko AkatsuEtsuro OgataNaokazu NagataYasuyuki KatayamaNobuo KugaiTakehiko MurakamiMiyuki NishikawaMark A. Thiede
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Lancet (1 paper)Journal of Clinical Investigation (2 papers)
- Partner nations
- JapanUnited StatesNetherlands
In The Last Decade
Michiko Yamamoto
119 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 151
- Orthopedics and Sports Medicine 363
- Nephrology 294
- Oncology 1.0k
- Molecular Biology 1.2k
- Endocrinology, Diabetes and Metabolism 265
Countries citing papers authored by Michiko Yamamoto
This map shows the geographic impact of Michiko Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiko Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiko Yamamoto more than expected).
Fields of papers citing papers by Michiko Yamamoto
This network shows the impact of papers produced by Michiko Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiko Yamamoto. The network helps show where Michiko Yamamoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michiko Yamamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 0 | |
| 2 | 2017 | 8 | |
| 3 | Amiodarone-induced agranulocytosis | 2015 | 1 |
| 4 | 2010 | 18 | |
| 5 | Frequency and causal factors of gastroesophageal reflux disease (GERD) in obstructive sleep apnea hypopnea syndrome: evaluation using the frequency scale for the symptoms of GERD | 2009 | 1 |
| 6 | 2009 | 62 | |
| 7 | 2008 | 30 | |
| 8 | 2008 | 2 | |
| 9 | 2006 | 8 | |
| 10 | 2005 | 18 | |
| 11 | 2001 | 1 | |
| 12 | 1998 | 39 | |
| 13 | 1998 | 164 | |
| 14 | 1998 | 64 | |
| 15 | 1998 | 106 | |
| 16 | [Autosomal dominant spinocerebellar degeneration with pigmentary retinopathy in a Japanese family]. | 1994 | 3 |
| 17 | 1993 | 26 | |
| 18 | 1991 | 46 | |
| 19 | 1989 | 109 | |
| 20 | 1989 | 17 |
About Michiko Yamamoto
Michiko Yamamoto is a scholar working on Toxicology, Nephrology and Oncology, having authored 126 papers that have together received 3.0k indexed citations. Recurring topics across this work include Bone health and treatments (16 papers), Bone Metabolism and Diseases (13 papers), Thyroid Disorders and Treatments (10 papers), Parathyroid Disorders and Treatments (10 papers), Lung Cancer Treatments and Mutations (9 papers), Pharmacy and Medical Practices (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Pharmacovigilance and Adverse Drug Reactions (7 papers). The work is most often cited by research in Orthopedics and Sports Medicine (363 citations), Nephrology (294 citations) and Oncology (1.0k citations). Michiko Yamamoto has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Takuhiko Akatsu, Etsuro Ogata, Naokazu Nagata, Yasuyuki Katayama, Nobuo Kugai, Takehiko Murakami, Miyuki Nishikawa, Mark A. Thiede, Katsuhiro Ono and Kazuo Motoyoshi. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.